Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Crisaborole with microneedling for vitiligo
Official title: Microneedling Combined With Topical Crisaborole 2 % Ointment in Treatment of Vitiligo. A Prospective Controlled Trial.
Status: Opening soon
Description:
Tanta University plans to enroll about 20 participants. Crisaborole is a topical PDE4 inhibitor that reduces inflammation, while microneedling may help it enter the skin. The combination may calm the local immune response and stimulate pigment return. Crisaborole is sold as Eucrisa for atopic dermatitis; vitiligo would be a new use. Possible effects include burning, stinging, redness, pain, bleeding, and rarely infection or an allergic reaction. The study record does not list an age range. Recruitment has not started, and no locations are listed yet.
Start date: August 01, 2025
Completion date: August 01, 2026
Organizer: Tanta University
Contact: See contacts and locations in the ClinicalTrials.gov record
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Red Wine and Vitiligo
Recent research has explored whether moderate red wine consumption might influence vitiligo risk, especially through genetic studies and large population data. What the Genetic ...
- What is the best therapy for localized vitiligo?
Localized vitiligo, where the white patches are limited to one or a few areas of the body, can be managed with a few treatment approaches. The best therapy usually depends on th...
- Vitiligo and hearing loss: any connection?
Vitiligo is primarily recognized for causing skin discoloration, but it can also impact melanocytes in unexpected areas, such as the inner ear. This raises questions about wheth...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.